Unstimulated whole salivary flow rate and anxiolytics intake are independently associated with oral Candida infection in patients with oral lichen planus

European Journal of Oral Sciences

Volumn 121, Issue 5, 2013, Pages 427-433

  Bokor Bratic, Marija ^a   Cankovic, Milos ^a   Dragnic, Natasa ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Institute for Public Health of Vojvodina   (Serbia)

Author keywords

Anxiolytics; Candida infection; Oral lichen planus; Salivary flow rate

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; AGED; ARTICLE; CANDIDIASIS; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; CULTURE TECHNIQUE; DRUG EFFECT; FEMALE; HUMAN; LICHEN PLANUS; MALE; MICROBIOLOGY; MIDDLE AGED; MOUTH LICHEN PLANUS; PHYSIOLOGY; PREVALENCE; RISK FACTOR; SALIVA; SALIVARY FLOW RATE; STATISTICAL MODEL; THRUSH;

ANXIOLYTICS; CANDIDA INFECTION; ORAL LICHEN PLANUS; SALIVARY FLOW RATE;

ADULT; AGED; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CANDIDIASIS, ORAL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CULTURE TECHNIQUES; FEMALE; HUMANS; LICHEN PLANUS, ORAL; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SALIVA;

EID: 84883821172     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/eos.12073     Document Type: Article

References (40)

1. Fotos PG, Vincent SD, Hellstein JW. Oral candidiasis. Oral Surg Oral Med Oral Pathol 1992; 74: 41-49.
2. Samaranayake LP. Host factors and oral candidosis. In: Samaranayake LP, Macfarlane TW, eds. Oral candidosis. London: Wright, 1990; 66-103.
3. Ellepola ANB, Samaranayake LP. Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis 2001; 7: 211-216.
4. Lundstrom IMC, Anneroth GB, Holmberg K. Candida in patients with oral lichen planus. Int J Oral Surg 1984; 13: 226-238.
5. Krogh P, Holmstrup P, Thorn JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987; 63: 48-54.
6. Simon M, Hornstein OP. Prevalence rate of Candida in the oral cavity of patients with oral lichen planus. Arch Dermatol Res 1980; 267: 317-318.
7. Gonzales-Garcia A, Diniz-Freitas M, Gandara-Vila P, Blanco-Carrion A, Garcia-Garcia A, Gandara-Rey JM. Triamcinolone acetonide mouth rinses for treatment of erosive oral lichen planus: efficacy and risk of fungal over-infection. Oral Dis 2006; 12: 559-565.
8. Vincent SD, Fotos PG, Baker KA, Williams TP. Oral lichen planus: the clinical, historical and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990; 70: 165-171.
9. Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 1992; 21: 456-458.
10. Thongprasom K, Luengvisut P, Wongwatanakij A, Boonjatturus C. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med 2003; 32: 315-322.
11. Lodi G, Tarozzi M, Sardella A, Demarosi F, Canegallo L, di Benedetto D, Carrassi A. Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. Brit J Dermatol 2007; 156: 1336-1341.
12. Jankittivong A, Kuvatanasuchati J, Pipattanagovit P, Sinheng W. Candida in oral lichen planus patients undergoing topical steroid therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 61-66.
13. van Meij EH, van Der WAAL. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003; 32: 507-512.
14. Sreebny LM, Zhu WX. The use of whole saliva in the differential diagnosis of Sjögren's syndrome. Adv Dent Res 1996; 10: 17-24.
15. Zeng X, Hou X, Wang Y, Jiang L, Xiong C, Zhou M, Chen Q. Carriage rate and virulence attributes of oral Candida albicans isolates from patients with oral lichen planus: a study in an ethnic Chinese cohort. Mycoses 2008; 52: 161-165.
16. Narhi TO, Ainamo A, Meurman JH. Salivary yeasts, saliva and oral mucosa in the elderly. J Dent Res 1993; 72: 1009-1014.
17. Torres SR, Peixoto CB, Caldas DM, Silva EB, Akiti T, Nucci M, de Uzeda M. Relationship between salivary flow rates and Candida counts in subjects with xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 149-154.
18. Navazesh M, Wood G, Brightman V. Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 284-288.
19. Tanida T, Ueta E, Tobiume A, Hamada T, Rao F, Osaki T. Influence of aging on candidal growth and adhesion regulatory agents in saliva. J Oral Pathol Med 2001; 30: 328-335.
20. Tanida T, Okamoto T, Okamoto A, Wang H, Hamada T, Ueta E, Osaki T. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J Oral Pathol Med 2003; 32: 586-594.
21. Wolff A, Zuk-Paz L, Kaplan I. Major salivary gland output differs between users and non-users of specific medication categories. Gerodontology 2008; 25: 210-216.
22. Torres SR, Peixoto CB, Caldas DM, Silva EB, Magalhaes FAC, Uzeda M, Nucci M. Clinical aspects of Candida species carriage in saliva of xerostomic subjects. Med Mycol 2003; 41: 411-414.
23. Kawaguchi M, Yamagishi H. Coupling of benzodiazepine and GABA(A) receptors in the salivary glands is a factor of drug-induced xerostomia. Int Acad Biomed Drug Res 1996; 11: 291-296.
24. Yamagishi H, Kawaguchi M. Characterization of central- and peripheral-type benzodiazepine receptors in rat salivary glands. Biochem Pharmacol 1998; 55: 209-214.
25. de Matos LF, Pereira SM, Kaminagakura E, Marques LS, Pereira CV, van der Bilt A, Pereira LJ. Relationships of beta-blockers and anxiolytics intake and salivary secretion, masticatory performance and taste perception. Arch Oral Biol 2010; 55: 164-169.
26. Scelza MFZ, Silva DD, Ahiadzro NK, da Silva LE, Scelza P. The influence of medication on salivary flow of the elderly: preliminary study. Gerodontology 2010; 27: 278-282.
27. Navazesh M, Brightman VJ, Pogoda JM. Relationship of medical status, medications, and salivary flow rates in adults of different ages. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81: 172-176.
28. Nedefors T, Dahlof C. Effects on salivary flow rate and composition of withdrawal of and re-expose to the beta 1-selective antagonist metoprolol in a hypertensive patient population. Eur J Oral Sci 1996; 104: 262-268.
29. Bergdahl M, Bergdahl J. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression and stress. J Dent Res 2000; 79: 1652-1658.
30. Nagler RM, Hershkovich O. Relationships between age, drugs, oral sensorial complaints and salivary profile. Arch Oral Biol 2005; 50: 7-16.
31. Khosravi AR, Yarahmadi S, Baiat M, Shokri H, Pourkabireh M. Factors affecting the prevalence of yeasts in the oral cavity of patients with diabetes mellitus. J Mycol Med 2008; 18: 83-88.
32. Kadir T, Pisiriciler R, Akyuz S, Yarat A, Emekli N, Ipbuker A. Mycological and cytological examination of oral candidal carriage in diabetic patients and non-diabetic control subjects: through analysis of local aetiologic and systemic factors. J Oral Rehabil 2002; 29: 452-457.
33. Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, Daniilidou N, Karamitsos D. Candidal overgrowth in diabetic patients: potential predisposing factors. Mycoses 2005; 48: 192-196.
34. Xue JL, Fan MW, Wang SZ, Chen XM, Li Y, Wang L. A clinical study of 674 patients with oral lichen planus in China. J Oral Pathol Med 2005; 34: 467-472.
35. Carbone M, Arduino PG, Carrozzo M, Gandolfo S, Argiolas MR, Bertolusso G, Conrotto D, Pentenero M, Broccoletti R. Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis 2009; 15: 235-243.
36. Daniluk T, Tokajuk G, Stokowska W, Fiedoruk K, Sciepuk M, Zaremba ML, Rozkiewicz D, Kedra BR. Occurrence rate of oral Candida albicans in denture wearer patients. Adv Med Sci 2006; 51: 77-80.
37. Abu-Elteen KH, Abu-Alteen RM. The prevalence of Candida albicans population in the mouths of complete denture wearers. New Microbiol 1998; 21: 41-48.
38. Malani AN, Psarros G, Malani PN, Kauffman CA. Is age a risk factor for Candida glabrata colonisation? Mycoses 2010; 54: 531-537.
39. Lockhart SR, Joly S, Vargas K, Swails-Wenger J, Enger L, Soll DR. Natural defense against Candida colonisation breakdown in the oral cavities of the elderly. J Dent Res 1999; 78: 857-868.
40. Al-Karaawi ZM, Manfredi M, Waugh ACW, McCullough MJ, Jorge J, Scully C, Porter SR. Molecular characterization of Candida spp. isolated from the oral cavities of patients from diverse clinical settings. Oral Microbiol Immunol 2002; 17: 44-47.